-
Is AbbVie's Acquisition of ImmunoGen a Strategic Move to Expand its Oncology Portfolio?
Pharmaceutical companies are constantly seeking new treatments to bolster their offerings, as drug patents eventually expire.
2023-12-27 14:08 -
BMS's Acquisition of Karuna Therapeutics: A Game-Changer in Neuroscience?
In a recent announcement, Bristol Myers Squibb (BMS) revealed its finalized acquisition agreement with Karuna Therapeutics, a company specializing in ...
2023-12-26 18:15 -
Is PCSK9 Small Nucleic Acid Drug the Future of Lipid-Lowering Therapy in China?
Could PCSK9 small nucleic acid drugs hold the key to the future of lipid-lowering therapy in China? Only time will tell, as the race for effective tre...
2023-12-26 17:44 -
Who Will Lead the Race in China's Booming CNS Drug Market?
The recent high-profile acquisitions in the pharmaceutical industry, including AbbVie's purchase of Cerevel Therapeutics and BMS's acquisition of Karu...
2023-12-26 16:58 -
Unveiling the Future of Blockbuster Drugs: What Lies Ahead for Pharmaceutical Powerhouses?
Since the introduction of Tagamet (cimetidine) in 1986, the first-ever blockbuster drug with sales exceeding $1 billion, pharmaceutical companies have...
2023-12-26 16:40 -
Who Will Be The Blockbuster Drug In 2024?
The pharmaceutical industry has long relied on blockbuster drugs to drive significant revenue and sustain profitability.
2023-12-26 16:18 -
'Zombie Deer' Virus Detected in Yellowstone Park, USA, Experts Warn: It may Infect Humans
In November, a carcass of a deer in Yellowstone Park reportedly tested positive for a highly contagious prion, a disease that affects the host's brain...
2023-12-25 16:33 -
Bridging Science and Business: Exploring the Dynamics of Biotech Innovation
The field of innovative pharmaceuticals, often referred to as biotech, revolves around the transformation of scientific breakthroughs into profitable ...
2023-12-22 17:31 -
GSK China's Strategic Restructuring to Regain Market Position
In recent news, it has been reported by industry media that GSK China is set to undergo a major restructuring starting from January 1, 2024.
2023-12-22 16:37 -
DMK Pharmaceuticals Announces Regaining Full Rights to ZIMHI® for Opioid Overdose Treatment
DMK Pharmaceuticals Corporation (Nasdaq: DMK) has recently regained complete commercialization rights for ZIMHI® (naloxone), a product aimed at treat...
2023-12-22 16:24
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- UBE Corporation Accelerates Ch... Jul 02, 2025
Related Products
Related Producers
